KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ECYT
Delisted

Endocyte Fund Price (Quote)

$23.99
+0 (+0%)
At Close: Jan 18, 2019

Range Low Price High Price Comment
30 days $23.97 $24.00 Friday, 18th Jan 2019 ECYT stock ended at $23.99. During the day the stock fluctuated 0% from a day low at $23.99 to a day high of $23.99.
90 days $23.37 $24.00
52 weeks $2.81 $24.00

Historical Endocyte prices

Date Open High Low Close Volume
Jan 18, 2019 $23.99 $23.99 $23.99 $23.99 0
Jan 17, 2019 $23.99 $23.99 $23.99 $23.99 0
Jan 16, 2019 $23.99 $23.99 $23.99 $23.99 0
Jan 15, 2019 $23.99 $23.99 $23.99 $23.99 0
Jan 14, 2019 $23.99 $23.99 $23.99 $23.99 0
Jan 11, 2019 $23.99 $23.99 $23.99 $23.99 0
Jan 10, 2019 $23.99 $23.99 $23.99 $23.99 0
Jan 09, 2019 $23.99 $23.99 $23.99 $23.99 0
Jan 08, 2019 $23.99 $23.99 $23.99 $23.99 0
Jan 07, 2019 $23.99 $23.99 $23.99 $23.99 0
Jan 04, 2019 $23.99 $23.99 $23.99 $23.99 0
Jan 03, 2019 $23.99 $23.99 $23.99 $23.99 0
Jan 02, 2019 $23.99 $23.99 $23.99 $23.99 0
Dec 31, 2018 $23.99 $23.99 $23.99 $23.99 0
Dec 28, 2018 $23.99 $23.99 $23.99 $23.99 0
Dec 27, 2018 $23.99 $23.99 $23.99 $23.99 0
Dec 26, 2018 $23.99 $23.99 $23.99 $23.99 0
Dec 24, 2018 $23.99 $23.99 $23.99 $23.99 0
Dec 21, 2018 $23.99 $23.99 $23.99 $23.99 0
Dec 20, 2018 $23.99 $24.00 $23.99 $23.99 2 340 222
Dec 19, 2018 $23.99 $24.00 $23.97 $24.00 2 261 770
Dec 18, 2018 $23.96 $23.99 $23.96 $23.97 2 611 909
Dec 17, 2018 $23.96 $23.98 $23.95 $23.96 3 719 446
Dec 14, 2018 $23.88 $23.88 $23.84 $23.84 1 472 160
Dec 13, 2018 $23.86 $23.90 $23.84 $23.86 1 265 343
Click to get the best stock tips daily for free!

About Endocyte

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trials to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of ad... ECYT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT